Aemetis Q2 2026: Revenue Up 20% on RNG Momentum, But GAAP Loss Persists as Credits Do Legwork

Key Q2 2026 metrics

• Revenue: $62.7 million, up 20% year over year.
• Gross profit: $13.5 million.
• Operating income: $5.8 million.
• Net loss: $9.4 million, an improvement of $14.0 million versus Q2 2025.
• Adjusted EBITDA: $9.7 million, up $15.5 million vs. Q2 2025.
• RNG sales volume: 146,900 MMBtu, up 38% from 106,400 MMBtu in Q2 2025.
• Tax credits: $8.6 million of Section 45Z production tax credits included in the results.
• Operational milestones: 10 digester cleanup skids received; two biogas dairy digesters expected to be commissioned in Q3.
• LCFS & pathways: 7 fully approved provisional LCFS pathways (negative ~380 CI score on average); 6 more biogas pathways nearing approval; two additional dairy digesters expected to be commissioned in Q3.

What this implies for AMTX and the sector

The headline numbers lean toward growth in revenue and a narrowing of the cash-consumed story, but the GAAP math still shows a net loss. That mix is not unusual for a growth-stage renewable fuels company riding a wave of government credits, ambitious capex, and a ramp-up in biogas capacity. The EPS story remains a non-story for now, since the release does not present a per-share figure; the absence of a visible EPS consensus or explicit revenue forecast for next quarter means investors are left to assume the catalysts will carry the freight.

The drive comes from multiple engines: California Ethanol and Dairy RNG are powering top-line growth, and Section 45Z credits plus LCFS credits are lifting margins in ways that actual products alone don’t. The RNG volume expansion (38% YoY) is especially notable because it signals material operating leverage as the business scales its digesters. If the next wave of digesters comes online in Q3 as planned, we should expect further lift to EBITDA—assuming the credit regime remains stable.

Management’s tone is pragmatic: the company is investing in process improvements (corn oil expansion, vapor recompression) and asset expansion (biogas digesters) to reduce energy costs and improve cash flow. The mechanical vapor recompression project, coupled with on-site solar, is designed to cut fossil natural gas use at Keyes ethanol—an efficiency story that can matter if energy prices stay volatile. The India Biodiesel subsidiary’s continued leadership adds a regional growth feather in the cap, though the broader policy backdrop remains the real swing factor.

Earnings metrics, credibility, and forward-looking signal

The absence of a reported EPS figure means this quarter’s narrative hinges on gross margin quality and cash-like EBITDA rather than GAAP net income. In other words, the market watches Adjusted EBITDA as a better compass for ongoing profitability, and AMTX’s $9.7 million figure—versus a year-ago improvement of $15.5 million—reads as a working progress chart, not a completed race.

Without a stated EPS consensus or a formal revenue forecast for upcoming quarters, there isn’t a clean “beat” or “miss” storyline to anchor a stock reaction. Instead, the narrative is: “growth exists, volatility persists, and credits are the ballast.” Investors will need to see continued RNG volume growth, more digesters online, and a trajectory toward cash flow positive operations before the earnings surprise meme moves from theory to practice.

Implications for peers and the sector

AMTX’s quarter underscores how policy-driven credits can shape the financial profile of biogas and renewable fuels players. If LCFS pathways keep progressing toward approval and credits stay accessible, sector peers with similar biogas assets could see favorable margin tailwinds, even as the bottom line remains volatile. The capacity ramp—10 digester skids received now, two digesters expected online in Q3—highlights a common playbook: accelerate asset growth on credit-enabled economics, while hoping for better energy prices or policy certainty to turn EBITDA into a durable positive cash flow story.

For peers, the message is not to time the market on policy alone, but to couple pipeline credits with real asset-scale RNG production and energy-saving initiatives. Companies betting on a robust LCFS/45Z environment should monitor policy stability, credit valuation, and throughput from ramping biogas assets. If these levers stay favorable, today’s Q2 cadence could become tomorrow’s quarterly rhythm for sector players—though not before the usual quarterly accounting drama plays out.

Notes on the disclosure and investor takeaways

The press release anchors its narrative in revenue growth and asset expansion rather than a clean profitability picture. The presence of $8.6 million in Section 45Z credits and active LCFS pathway development is a recurring theme; for investors, these credits are the “earnings turbocharger” whenever policy and credit markets cooperate.

In sum, AMTX delivered a credible topline uptick and meaningful RNG volume growth, supported by an improving EBITDA trajectory and ongoing capital projects. The key asks for the next print are clear: maintain RNG throughput, accelerate digester commissioning, and deliver clarity on EPS and forward revenue expectations to convert the progress into a more durable earnings narrative.